VSV-G vaccine (Mayo/ICRF)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameVSV-G vaccine (Mayo/ICRF)
Drug Alias Nameneuroblastoma vaccine (Mayo)vesicular stomatitis virus glycoprotein vaccine (Mayo)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNervous System NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe UK Imperial Cancer Research FundMayo Clinic
Active IndicationsN/A
Inactive IndicationsNervous System NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A